Cargando…
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor()
BACKGROUND: Hereditary angioedema (HAE) is often caused by low serum levels or functional deficiency in C1 inhibitor (C1-INH); however, in some cases, C1-INH serum level and function are measured as normal (HAE-nl-C1INH). Management of HAE-nl-C1INH is similar to management of HAE with C1-INH deficie...
Autores principales: | Jones, Douglas H., Bansal, Priya, Bernstein, Jonathan A., Fatteh, Shahnaz, Harper, Joseph, Hsu, F. Ida, O’Connor, Maeve, Park, Nami, Suez, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804245/ https://www.ncbi.nlm.nih.gov/pubmed/35145604 http://dx.doi.org/10.1016/j.waojou.2021.100621 |
Ejemplares similares
-
Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor
por: Jones, Douglas, et al.
Publicado: (2023) -
The multifactorial impact of receiving a hereditary angioedema diagnosis
por: Raasch, Jason, et al.
Publicado: (2023) -
Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
por: Riedl, Marc
Publicado: (2015) -
Hereditary Angioedema with Normal C1 Esterase Inhibitor Refractory to Long-Term Prophylaxis: A Case Report
por: Cobb, Gavin, et al.
Publicado: (2023) -
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
por: Reshef, Avner, et al.
Publicado: (2019)